Previous issue | Next issue | Archive | Cover PDF
Volume 4 (1); 2014
Research Papers
ROS-Responsive Activatable Photosensitizing Agent for Imaging and Photodynamic Therapy of Activated Macrophages
Hyunjin Kim, Youngmi Kim, In-Hoo Kim, Kyungtae Kim, Yongdoo Choi
Theranostics 2014; 4(1): 1-11. doi:10.7150/thno.7101
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Gold Nanoshelled Liquid Perfluorocarbon Magnetic Nanocapsules: a Nanotheranostic Platform for Bimodal Ultrasound/Magnetic Resonance Imaging Guided Photothermal Tumor Ablation
Hengte Ke, Jinrui Wang, Sheng Tong, Yushen Jin, Shumin Wang, Enze Qu, Gang Bao, Zhifei Dai
Theranostics 2014; 4(1): 12-23. doi:10.7150/thno.7275
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Towards Stratifying Ischemic Components by Cardiac MRI and Multifunctional Stainings in a Rabbit Model of Myocardial Infarction
Yuanbo Feng, Feng Chen, Zhanlong Ma, Frederik Dekeyzer, Jie Yu, Yi Xie, Marlein Miranda Cona, Raymond Oyen, Yicheng Ni
Theranostics 2014; 4(1): 24-35. doi:10.7150/thno.7188
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Intravascular Photoacoustics for Image-Guidance and Temperature Monitoring During Plasmonic Photothermal Therapy of Atherosclerotic Plaques: A Feasibility Study
Doug Yeager, Yun-Sheng Chen, Silvio Litovsky, Stanislav Emelianov
Theranostics 2014; 4(1): 36-46. doi:10.7150/thno.7143
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
In Vivo Theranostics at the Peri-Infarct Region in Cerebral Ischemia
Jesús Agulla, David Brea, Francisco Campos, Tomás Sobrino, Bárbara Argibay, Wajih Al-Soufi, Miguel Blanco, José Castillo, Pedro Ramos-Cabrer
Theranostics 2014; 4(1): 90-105. doi:10.7150/thno.7088
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
uPAR-targeted Optical Imaging Contrasts as Theranostic Agents for Tumor Margin Detection
Lily Yang, Hari Krishna Sajja, Zehong Cao, Weiping Qian, Laura Bender, Adam I. Marcus, Malgorzata Lipowska, William C. Wood, Y. Andrew Wang
Theranostics 2014; 4(1): 106-118. doi:10.7150/thno.7409
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Reviews
Prospective of 68Ga-Radiopharmaceutical Development
Irina Velikyan
Theranostics 2014; 4(1): 47-80. doi:10.7150/thno.7447
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]
Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
Hisataka Kobayashi, Rira Watanabe, Peter L. Choyke
Theranostics 2014; 4(1): 81-89. doi:10.7150/thno.7193
[Abstract]
[Full text]
[PDF] [PubMed]
[PMC]